Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -.--% |
2019 | Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc. | CI |
2018 | PhaseRx, Inc. Bankruptcy Case Dismissed | CI |
Chart calendar PhaseRx, Inc.
Upcoming events on PhaseRx, Inc.
No events available
Past events on PhaseRx, Inc.
2019-08-04 | Interim 2019 Earnings Release |
Annual results
Fiscal Period | December | 2016 |
---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -10,8 -18,4 41.12% |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - |
Net income | Released Forecast Spread | 0,00 0,00 - |
EPS | Released Forecast Spread | 0,00 0,00 - |
Announcement Date | 27/03/17 |
Past sector events for PhaseRx, Inc.
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
- Stock Market
- Equities
- PZRXQ Stock
- Calendar PhaseRx, Inc.